Snehal G. Thakkar

643 total citations
18 papers, 427 citations indexed

About

Snehal G. Thakkar is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Snehal G. Thakkar has authored 18 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Snehal G. Thakkar's work include Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Snehal G. Thakkar is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Snehal G. Thakkar collaborates with scholars based in United States. Snehal G. Thakkar's co-authors include Alan Wong, Michael Davidson, Naveen D. Bhandarkar, John K. Hix, Martin J. Schreiber, Paul Elson, Toni K. Choueiri, Jorge A. García, Brad Pohlman and Carlos Alemany and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Snehal G. Thakkar

16 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Snehal G. Thakkar United States 9 207 141 128 110 69 18 427
Emre Tüzel Türkiye 15 236 1.1× 74 0.5× 129 1.0× 55 0.5× 31 0.4× 35 567
Ilaria Fiordoliva Italy 13 316 1.5× 156 1.1× 102 0.8× 58 0.5× 22 0.3× 22 468
Yonghui Chen China 13 435 2.1× 114 0.8× 230 1.8× 90 0.8× 20 0.3× 72 654
Bahriye Payzın Türkiye 9 82 0.4× 268 1.9× 38 0.3× 26 0.2× 36 0.5× 33 450
Paul Zorsky United States 10 56 0.3× 208 1.5× 82 0.6× 19 0.2× 46 0.7× 16 399
Cyril Cyrus Saudi Arabia 12 28 0.1× 56 0.4× 97 0.8× 53 0.5× 46 0.7× 42 396
Raj Warrier United States 13 64 0.3× 68 0.5× 59 0.5× 25 0.2× 41 0.6× 46 386
Bernard L. Zidar United States 15 345 1.7× 170 1.2× 75 0.6× 27 0.2× 40 0.6× 22 632
Qilong Yi United States 11 77 0.4× 85 0.6× 74 0.6× 23 0.2× 18 0.3× 17 421
Dimitrios Delakas Greece 13 287 1.4× 69 0.5× 159 1.2× 100 0.9× 19 0.3× 24 559

Countries citing papers authored by Snehal G. Thakkar

Since Specialization
Citations

This map shows the geographic impact of Snehal G. Thakkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Snehal G. Thakkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Snehal G. Thakkar more than expected).

Fields of papers citing papers by Snehal G. Thakkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Snehal G. Thakkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Snehal G. Thakkar. The network helps show where Snehal G. Thakkar may publish in the future.

Co-authorship network of co-authors of Snehal G. Thakkar

This figure shows the co-authorship network connecting the top 25 collaborators of Snehal G. Thakkar. A scholar is included among the top collaborators of Snehal G. Thakkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Snehal G. Thakkar. Snehal G. Thakkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Carter, Gebra Cuyún, et al.. (2024). Value of next generation sequencing (NGS) testing in advanced cancer patients. Journal of Medical Economics. 27(1). 519–530. 2 indexed citations
2.
Basu, Gargi D., Niru Chennagiri, Turgut Dogruluk, et al.. (2024). Abstract PO5-13-06: Classifying HER2-low breast cancer using a combination of ERBB2 mRNA expression and altered genes. Cancer Research. 84(9_Supplement). PO5–13. 1 indexed citations
3.
Gibbs, Sarah N., Desi Peneva, Gebra Cuyún Carter, et al.. (2023). Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer. JCO Precision Oncology. 7(7). e2200715–e2200715. 28 indexed citations
4.
Basu, Gargi D., David W. Hall, Janine LoBello, et al.. (2023). The genomic landscape of TERT alterations in bladder cancer.. Journal of Clinical Oncology. 41(6_suppl). 551–551.
5.
Edwards, David K., David W. Hall, Janine LoBello, et al.. (2023). Genomic profiling of biliary tract carcinomas by their location.. Journal of Clinical Oncology. 41(16_suppl). e16175–e16175.
6.
Josefson, D., David W. Hall, Ariane Kemkes, et al.. (2023). Abstract 2150: CLDN18/ARHGAP26 fusions in gastric cancers. Cancer Research. 83(7_Supplement). 2150–2150. 1 indexed citations
7.
Niu, Jiaxin, et al.. (2022). BRAF mutation classes and co-occurring mutations in NSCLC.. Journal of Clinical Oncology. 40(16_suppl). 9083–9083. 1 indexed citations
8.
Thakkar, Snehal G., Alex Z. Fu, John Sweetenham, et al.. (2008). Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer. 112(10). 2233–2240. 26 indexed citations
9.
Thakkar, Snehal G., et al.. (2007). Intimal pulmonary artery sarcoma presenting as dyspnea: case report. PubMed. 4(1). 14–14. 14 indexed citations
10.
Thakkar, Snehal G., David M. Peereboom, Thomas Olencki, et al.. (2006). Short Communication: Phase I Clinical and Gene Modulatory Evaluation of Tamoxifen and IFN- α 2b. Journal of Interferon & Cytokine Research. 26(11). 800–803. 2 indexed citations
11.
Thakkar, Snehal G., Toni K. Choueiri, & Jorge A. García. (2006). Endothelin receptor antagonists: Rationale, clinical development, and role in prostate cancer therapeutics. Current Oncology Reports. 8(2). 108–113. 12 indexed citations
12.
Choueiri, Toni K., Robert Dreicer, Brian I. Rini, et al.. (2006). Phase II study of lenalidomide in patients with metastatic renal cell carcinoma. Cancer. 107(11). 2609–2616. 44 indexed citations
13.
14.
15.
Alemany, Carlos, Brad Pohlman, Paul Elson, et al.. (2005). Expression of bcl-2 in Classical Hodgkin's Lymphoma: An Independent Predictor of Poor Outcome. Journal of Clinical Oncology. 23(16). 3773–3779. 51 indexed citations
16.
Clemente, Michael J., Emilio D. Poggio, Ronald Bukowski, et al.. (2005). Heterogeneous Alterations in Human Alloimmunity Associated with Immunization. Transplantation. 80(3). 297–302. 16 indexed citations
17.
Davidson, Michael, Snehal G. Thakkar, John K. Hix, et al.. (2004). Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. The American Journal of Medicine. 116(8). 546–554. 215 indexed citations
18.
Thakkar, Snehal G., et al.. (2004). Bisphosphonate Therapy Associated with an Increased Incidence of Mandibular/Maxillary Osteomyelitis in Multiple Myeloma Patients.. Blood. 104(11). 4925–4925. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emre Tüzel Breakdown of academic impact, for papers by Ilaria Fiordoliva Breakdown of academic impact, for papers by Yonghui Chen Breakdown of academic impact, for papers by Bahriye Payzın Breakdown of academic impact, for papers by Paul Zorsky Breakdown of academic impact, for papers by Cyril Cyrus Breakdown of academic impact, for papers by Raj Warrier Breakdown of academic impact, for papers by Bernard L. Zidar Breakdown of academic impact, for papers by Qilong Yi Breakdown of academic impact, for papers by Dimitrios Delakas
Rankless by CCL
2026